Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Plus Therapeutics Inc (NQ: PSTV ) 1.540 +0.040 (+2.67%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Plus Therapeutics Inc < Previous 1 2 3 4 5 6 7 Next > PSTV Stock Earnings: Plus Therapeutics Beats EPS, Misses Revenue for Q1 2024 May 15, 2024 PSTV stock results show that Plus Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense April 22, 2024 Plus Therapeutics will secure $3 million in funding from the Department of Defense for pediatric brain cancer trial expansion. Via Benzinga PSTV Stock Earnings: Plus Therapeutics Beats EPS, Beats Revenue for Q4 2023 March 05, 2024 PSTV stock results show that Plus Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. Via InvestorPlace Recap: Plus Therapeutics Q4 Earnings March 05, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session November 20, 2023 Via Benzinga Insiders Buying Plus Therapeutics And 2 Other Stocks Under $2 November 09, 2023 The Dow Jones closed lower by around 40 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Why Plus Therapeutics Stock Popped Today November 01, 2023 PLUS THERAPEUTICS, Inc. (NASDAQ: PSTV) shares are trading higher on Wednesday. Via Benzinga Earnings Outlook For Plus Therapeutics October 30, 2023 Via Benzinga Plus Therapeutics Earnings Preview August 11, 2023 Via Benzinga Earnings Scheduled For March 5, 2024 March 05, 2024 Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. Via Benzinga Plus Therapeutics Earnings Preview March 04, 2024 Via Benzinga Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 01, 2023 Gainers Via Benzinga Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket November 01, 2023 Gainers Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday November 01, 2023 We're starting off Wednesday with a breakdown of the biggest pre-market stock movers investors will want to keep track of today! Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session October 31, 2023 Via Benzinga Why Is Liquid Biopsy Firm Biocept Stock Trading Lower Today? October 16, 2023 Biocept Inc (NASDAQ: BIOC) filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. Via Benzinga Topics Bankruptcy Exposures Financial Legal 12 Health Care Stocks Moving In Friday's After-Market Session September 29, 2023 Via Benzinga Earnings Scheduled For October 31, 2023 October 31, 2023 Companies Reporting Before The Bell • BBVA (NYSE:BBVA) is likely to report earnings for its third quarter. • BP (NYSE:BP) is expected to report quarterly earnings at $1.37 per share on revenue of... Via Benzinga Plus Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying September 18, 2023 The Dow Jones closed lower by close to 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session September 11, 2023 Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session September 11, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 08, 2023 Via Benzinga Why Is Cancer Diagnostic Focused Biocept Stock Trading Higher Today? September 08, 2023 Biocept Inc (NASDAQ: BIOC) shares are trading higher after the company signed a non-exclusive licensing agreement for CNSide with Plus Therapeutics Inc (NASDAQ: PSTV), which expands the comprehensive... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday September 08, 2023 Pre-market stock movers are a hot topic worth checking out on Friday with a look at the biggest winners and losers today! Via InvestorPlace EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers September 08, 2023 Plus Therapeutics Inc (NASDAQ: PSTV) has expanded its supply agreement with Biocept Inc (NASDAQ: BIOC) by acquiring an option to exclusively license Biocept's CNSide, a cerebrospinal flu Via Benzinga Plus Therapeutics Presents Exciting New Clinical Data At Top Cancer Conference August 14, 2023 Marc Hedrick, President & CEO of Plus Therapeutics (NASDAQ: PSTV), was a guest on Benzinga’s All-Access. Via Benzinga Earnings Scheduled For August 14, 2023 August 14, 2023 Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million. Via Benzinga Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session August 11, 2023 Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy. Via Benzinga Topics Bankruptcy Exposures Financial Legal EXCLUSIVE: Plus Therapeutics Lead Candidate Shows Preliminary Safety, Efficacy In Type Of Brain Cancer August 11, 2023 Plus Therapeutics Inc (NASDAQ: PSTV) reported data from the ReSPECT-LM study evaluating the company’s lead radiotherapeutic, rhenium (186Re) obisbemeda, for Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session July 26, 2023 Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.